paraxanthine catalase glutathione outperforms caffeine as a cognitive enhancer in new preclinical study paraxanthine glutathione catalase New Preclinical

While TGA-approved peptide-based medicines such as semaglutide and tirzepatide have undergone extensive trials and have strongly backed evidence, Dr Kelly said there is limited scientific evidence behind the claims being made for other peptide products promoted and sold online

10.1016/j.mehy.2006.02.040 Med

According to Ghiyam, researchers were particularly concerned about uncontrolled darkening of existing moles and other pigmentation changes, which contributed to the decision not to approve the drug

Data on the safety and efficacy of such therapies over decades are lacking, creating uncertainty about their role in chronic use, Roberts says